News
Jumpcode Genomics Announces License Agreement with ERS Genomics
License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation sequencing capabilities Dublin, Ireland, and San Diego, CA, 27 March, 2025: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Jumpcode Genomics (‘Jumpcode’), a life science tools company improving and reducing the cost of next-generation sequencing technology, today announced a non-exclusive CRISPR/Cas9 […]
New Study Shows Improved Genotyping by Sequencing with in vitro Repeat Depletion
SAN DIEGO, Calif. – June 20, 2023 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced the results of a study demonstrating the ability to improve genotyping through CRISPR-Cas9-based in vitro repeat depletion, a new method for high-throughput genotyping where repetitive fragments are removed prior to […]
New Research Demonstrates Potential of Jumpcode Genomics Depletion Technology to Improve Pandemic Response
SAN DIEGO, Calif. – May 1, 2023 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, together with the Translational Genomics Research Institute (TGen), part of City of Hope, today announced the results of a new study demonstrating the potential of Jumpcode Genomics depletion technology for improving future large-scale infectious […]
Jumpcode Genomics joins PacBio Compatible Program
Combination of Jumpcode Single Cell RNA Boost Kit and PacBio MAS-Seq for 10x Single Cell 3′ kit maximizes usable single cell RNA sequencing data About Jumpcode Genomics Jumpcode Genomics is changing genomics with technology that allows scientists to break barriers limiting their research. Combining CRISPR-based technology and next-generation sequencing it’s now possible to search for […]
Jumpcode Genomics Joins 10x Genomics’ Compatible Partner Program (CPP)
Powerful combination of Jumpcode Single Cell RNA Boost Kit and 10x Genomics Chromium Single Cell Gene Expression platform enables scientists to boost single cell RNA sequencing. SAN DIEGO, Calif. – November 30, 2022 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced a partnership with 10x […]
Jumpcode Genomics Unveils an Expanded CRISPRclean® RNA Depletion Portfolio to Boost Discovery
Innovative new technologies empower medical and biopharma scientists and researchers to extract greater insights from the transcriptome. SAN DIEGO, Calif. – October 18, 2022 Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today introduced an expanded portfolio of RNA depletion technologies to enable researchers to extract greater insights […]